Melanoma maligno en paciente con enfermedad de Crohn y tratamiento con anti-TNF alfa

Alcalde Vargas, Alfonso; Trigo Salado, Claudio; Leo Carnerero, Eduardo; Lorente Lavirgen, Ana Isabel.
Rev. esp. enferm. dig ; 105(10): 639-640, nov.-dic. 2013. ilus
Artículo en Español | IBECS (España) | ID: ibc-119297

Documentos relacionados

  1. Single-Cell Analysis of Crohn's Disease Lesions Identifies a Pathogenic Cellular Module Associated with Resistance to Anti-TNF Therapy.
  2. Infliximab-induced amicrobial pustulosis of the folds in a patient with Crohn disease.
  3. Development of an MRI-Based Prediction Model for Anti-TNF Treatment Failure in Perianal Crohn's Disease: A Multicenter Study.
  4. Pyoderma gangrenosum and impact on quality of life: A narrative review.
  5. Transmural or mucosal healing in Crohn´s disease. Which is the goal to be pursued?
  6. Pustular lesions in patients with Crohn disease and treatment with tumour necrosis factor-α inhibitors.
  7. Body Composition Predictors of Complicated Crohn's Disease.
  8. Strategies to Optimize Anti-tumor Necrosis Factor Therapy for Perianal Fistulizing Crohn's Disease: A Systematic Review.
  9. Phenotype of Crohn's disease according to the Montreal classification in relation to dental health status.
  10. Microgranulomas at Diagnosis Are Associated With Need for Antitumor Necrosis Factor Escalation in Pediatric Crohn Disease.